ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

XGN Exagen Inc

1.40
0.015 (1.08%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Exagen Inc XGN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.015 1.08% 1.40 19:00:00
Open Price Low Price High Price Close Price Previous Close
1.38 1.3606 1.42 1.40 1.385
more quote information »

Recent News

Date Time Source Heading
4/30/202415:05GLOBEExagen to Announce First Quarter 2024 Results on May 13,..
4/26/202407:30GLOBEExagen Inc. Announces Changes to the Board of Directors
3/18/202407:00GLOBEExagen Inc. Reports Strong Fourth Quarter and Full-Year 2023..
3/18/202406:12IHMARKETNEWSAnticipation Builds on Wall Street for Federal Reserve’s..
3/08/202408:00GLOBEExagen Inc. to Participate in the KeyBanc Capital..
3/07/202415:05GLOBEExagen to Announce Fourth Quarter 2023 and Full-Year..
3/06/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202415:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202415:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202415:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202406:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202415:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/08/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202414:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/30/202415:05GLOBEExagen Inc. to Participate in the 2024 BTIG MedTech, Digital..
1/22/202415:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/08/202407:00EDGAR2Form 8-K - Current report
1/07/202411:00GLOBEExagen Inc. Announces Select Preliminary Full-Year 2023..
12/11/202315:05EDGAR2Form 8-K - Current report
11/29/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
11/29/202316:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/27/202315:05EDGAR2Form S-3/A - Registration statement under Securities Act of..
11/20/202307:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/17/202315:30EDGAR2Form 8-K - Current report
11/17/202315:06EDGAR2Form S-3 - Registration statement under Securities Act of..
11/13/202316:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202315:05EDGAR2Form 8-K - Current report
11/13/202315:05GLOBEExagen Inc. Reports Strong Third Quarter 2023 Results
11/09/202315:05GLOBEExagen Inc. and Johns Hopkins University Announce License..
11/02/202315:05GLOBEExagen Inc. to Participate in the 2023 Canaccord Genuity..
10/30/202315:05GLOBEExagen to Announce Third Quarter 2023 Financial Results on..
10/18/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/17/202313:50DJNExagen Agrees to Pay Over $650K to Resolve Kickback..
9/28/202315:05GLOBEExagen Announces Acceptance of Multiple Abstracts at ACR..
9/12/202315:05GLOBEExagen Inc. to Participate in the 2023 Cantor Fitzgerald..
9/06/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/07/202308:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202307:00EDGAR2Form 8-K - Current report
8/07/202307:00GLOBEExagen Inc. Reports Strong Second Quarter 2023 Results
7/26/202315:05GLOBEExagen Inc. to Participate in the Canaccord Genuity 43rd..
7/25/202315:05GLOBEExagen to Announce Second Quarter 2023 Financial Results on..
7/24/202315:05EDGAR2Form 8-K - Current report
7/24/202315:05GLOBEExagen Inc. Appoints Paul Kim to Board of Directors
5/30/202308:00GLOBEExagen Inc. to Participate in the William Blair 43rd Annual..
5/15/202315:05GLOBEExagen Inc. Reports First Quarter 2023 Results

Your Recent History

Delayed Upgrade Clock